Experimental nasal influenza vaccine tested in kids, teens

(NIH/National Institute of Allergy and Infectious Diseases) An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit (VTEU) site at Saint Louis University, St. Louis, Missouri. The VTEU is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. (Source: EurekAlert! - Infectious and Emerging Diseases)

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Nnb9MP